SystHERs Study

Study #ML28257

Condition / Intervention

Metastatic Breast Cancer


An observational cohort study of treatment patterns and outcomesin patients with HER2 positive metastatic breast cancer.


Neal A Fischbach, MD

Contact Information

For more information about this study and to inquire about eligibility, (203) 384-3611

More Information

View this trial on


Inclusion Criteria:

  • Adult patients, >/=18 years of age
  • Initial diagnosis of HER2+ MBC, as diagnosed by the treating physician, no more than 6 months prior to study enrollment
  • Availability of cancer-specific historical data points in the patient's medical records